Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nicotinamide nucleotide transhydrogenase is an integral enzyme of the inner mitochondrial membrane that couples hydride transfer from NADH to NADP+ with proton translocation across the membrane. This process regenerates NADPH, which is essential for antioxidant defense and protecting mitochondrial and cellular components from oxidative damage. NNT plays a central role in cellular redox balance, particularly in tissues like adrenal glands, heart, kidneys, and fat. Its deficiency causes familial glucocorticoid deficiency, a rare disorder linked to adrenal insufficiency and increased oxidative stress. Structurally, it is a homodimeric protein complex with three main domains for substrate binding and proton transport. Research has not identified clinically approved drugs that directly modulate NNT activity, but its function is a key area of interest for mitochondrial biology and redox therapeutics.
(Hypothetical) Modulate enzyme activity: drugs could increase or decrease NADPH regeneration or alter proton translocation. Antioxidant modulation: compounds might enhance ROS clearance via upregulating or mimicking NNT function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide nucleotide transhydrogenase (NNT).